ストックスクリーナーアプリを入手
17.30
1.23%
0.21
前日終値:
$17.09
開ける：
$17.05
24時間の取引高:
214.07K
Relative Volume:
0.45
時価総額：
$463.94M
収益：
$31.38M
当期純損益:
$-6.69M
株価収益率:
-66.54
EPS:
-0.26
ネットキャッシュフロー:
$-1.84M
1週間 パフォーマンス:
+1.53%
1か月 パフォーマンス:
+18.57%
6か月 パフォーマンス:
+19.23%
1年 パフォーマンス:
+307.06%
1日の値動き範囲:
$17.02
$17.70
1週間の範囲:
$15.60
$17.70
52週間の値動き範囲:
$4.23
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
名前
Eton Pharmaceuticals Inc
セクター
電話
(847) 787-7361
住所
21925 W. FIELD PARKWAY, DEER PARK, IL
ETON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
17.30 | 439.00M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-01-10 | 開始されました | B. Riley Securities | Buy |
| 2025-01-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-09-04 | 再開されました | H.C. Wainwright | Buy |
| 2024-05-06 | 開始されました | Craig Hallum | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-01-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-09-20 | 開始されました | B. Riley FBR | Buy |
| 2019-06-10 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Eton Pharmaceuticals Inc (ETON) 最新ニュース
Eton Pharmaceuticals to host 1x1 meetings at 2025 Wells Fargo Healthcare Conference. - AInvest
Eton Pharmaceuticals: A Rare Disease Innovator with Strategic Momentum and Investor Appeal - AInvest
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference - GlobeNewswire
Rare Disease Drug Developer Eton Pharmaceuticals to Meet Investors at Wells Fargo Healthcare Conference - Stock Titan
What institutional flow reveals about Eton Pharmaceuticals Inc.Portfolio Return Summary & Weekly High Return Stock Opportunities - Newser
Why Eton Pharmaceuticals Inc. is moving todayJuly 2025 Earnings & Smart Money Movement Alerts - Newser
Can Eton Pharmaceuticals Inc. recover in the next quarter2025 Winners & Losers & High Accuracy Investment Entry Signals - Newser
Smart tools for monitoring Eton Pharmaceuticals Inc.’s price actionVolume Spike & Proven Capital Preservation Methods - Newser
Live market analysis of Eton Pharmaceuticals Inc.July 2025 Institutional & Expert Approved Trade Ideas - Newser
Is Eton Pharmaceuticals Inc. trending in predictive chart modelsWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Building trade automation scripts for Eton Pharmaceuticals Inc.Breakout Watch & Capital Efficient Trade Techniques - Newser
Chart overlay techniques for tracking Eton Pharmaceuticals Inc.2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
Can technical indicators confirm Eton Pharmaceuticals Inc.’s reversalSell Signal & Growth Focused Entry Reports - Newser
Order flow analysis tools used on Eton Pharmaceuticals Inc.IPO Watch & Weekly Top Stock Performers List - Newser
Is now a turning point for Eton Pharmaceuticals Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Will Eton Pharmaceuticals Inc. Bounce From 52 Week LowWeekly Profit Summary & Growth Focused Entry Point Reports - newsimpact.co.kr
Eton Pharma Accuses Supplement Maker of Trademark Infringement - Bloomberg Law News
Quantitative breakdown of Eton Pharmaceuticals Inc. recent moveWeekly Profit Report & Reliable Volume Spike Trade Alerts - Newser
What data driven models say about Eton Pharmaceuticals Inc.’s futureWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
Is Eton Pharmaceuticals Inc. stock entering bullish territoryGap Down & Daily Risk Controlled Trade Plans - Newser
How high can Eton Pharmaceuticals Inc. stock goJuly 2025 Decliners & Community Consensus Picks - Newser
What does recent volatility data suggest for Eton Pharmaceuticals Inc.2025 Bull vs Bear & High Accuracy Trade Signal Alerts - Newser
Detecting support and resistance levels for Eton Pharmaceuticals Inc.Market Growth Report & High Conviction Investment Ideas - Newser
Signal strength of Eton Pharmaceuticals Inc. stock in tech scannersWeekly Trade Analysis & Technical Buy Zone Confirmations - Newser
Eton Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingEarnings Performance Report & Daily Oversold Stock Bounce Ideas - Newser
Visualizing Eton Pharmaceuticals Inc. stock with heatmapsJuly 2025 Chart Watch & Daily Market Momentum Tracking - Newser
Published on: 2025-08-15 17:26:08 - Newser
What makes Eton Pharmaceuticals Inc. stock price move sharply2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
How Eton Pharmaceuticals Inc. stock reacts to Fed policy changesJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Is Eton Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Retail & Low Risk High Reward Trade Ideas - 선데이타임즈
Identifying reversal signals in Eton Pharmaceuticals Inc.2025 Valuation Update & High Accuracy Trade Alerts - Newser
XTX Topco Ltd Sells 2,858 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat
Published on: 2025-08-13 17:16:40 - 선데이타임즈
How to interpret RSI for Eton Pharmaceuticals Inc. stock [Gap Up]Free Low Drawdown Trading Techniques - Newser
Eton Pharmaceuticals Reports Strong Q2 Growth Amid Challenges - TipRanks
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript - Insider Monkey
With 43% Ownership in Eton Pharmaceuticals, Inc. (NASDAQ:ETON), Institutional Investors Have a Lot Riding on the Business - 富途牛牛
Loss-Making Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Set To Breakeven - simplywall.st
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates - MSN
Eton Pharmaceuticals Experiences Record Revenue Growth and Analysts See Significant Upside Potential - AInvest
Eton targets $80M revenue run-rate in Q3 2025 as product launches accelerate - MSN
Tools to monitor Eton Pharmaceuticals Inc. recovery probabilityWeekly Breakout Forecast with Entry Zones - Newser
Is Eton Pharmaceuticals Inc. stock reversal real or fakeTrade Safety Matrix for Conservative Traders - Newser
Eton (ETON) Q2 Revenue Jumps 108% - AOL.com
Wall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to Hold - Defense World
Published on: 2025-08-08 22:55:40 - Newser
Eton Pharmaceuticals 2025 Q2 Earnings Narrowed Losses and Strong Revenue Growth - AInvest
Eton Pharmaceuticals Inc (ETON) 財務データ
収益
当期純利益
現金流量
EPS
Eton Pharmaceuticals Inc (ETON) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Krempa David | Chief Business Officer |
Jun 12 '25 |
Sale |
14.92 |
16,977 |
253,297 |
629,669 |
| Krempa David | Chief Business Officer |
Jun 16 '25 |
Sale |
14.73 |
10,223 |
150,585 |
612,646 |
| Krempa David | Chief Business Officer |
Jun 13 '25 |
Sale |
14.77 |
6,800 |
100,436 |
622,869 |
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Buy |
15.82 |
7,930 |
125,484 |
2,770,000 |
2.37%
0.37%
大文字化:
|
ボリューム (24 時間):